Senior Multimedia Reporter
radhica.sookraj@guardian.co.tt
Health Minister Lackram Bodoe says the government has taken a major step toward modernising the country’s pharmaceutical regulatory system with the launch of a national drug database, while urging pharmacists to remain vigilant as challenges in the sector persist.
The new online platform, called the Regulated Medicines and Substances Portal, was launched by the Ministry of Health in collaboration with the Chemistry, Food and Drugs Division. It allows the public to search for information on registered pharmaceutical products approved for use in Trinidad and Tobago.
Bodoe described the initiative as a significant milestone in strengthening oversight within the health sector.
“Today marks an important milestone in our collective effort to modernise health systems and strengthen regulatory oversight in Trinidad and Tobago,” he said.
Bodoe explained that every product listed on the database has been formally authorised through the regulatory process and published through official Gazette notices.
“This system has been designed and implemented with strong safeguards for data privacy, security, and governance. For the public, the information available through the ministry’s website consists only of approved and publishable drug registration data,” he said.
He added that the system will require continued collaboration between regulators and industry stakeholders to remain effective.
“It is through sustained collaboration that we will maintain and strengthen the system. Together, we must ensure the drug database remains an active tool, responsive to the evolving needs of our health sector and protective of the trust placed in us,” Bodoe said.
Alyson Pouchet, President of the Trinidad and Tobago Pharmaceutical Society (TPSTT), congratulated the ministry on introducing the digital portal, noting that it represents years of work by government officials and industry stakeholders to modernise the regulatory framework.
Pouchet said the platform digitises historic drug registration records that were previously scattered across legal notices and archived documents, making it easier to search thousands of registered medicines and improving transparency in the regulatory process.
However, she cautioned that the database does not replace the professional responsibility of pharmacists.
She added that pharmacists remain the final safeguard against substandard or falsified medicines and stressed that regulatory oversight at the country’s ports of entry is essential to protecting the national drug supply.
The development comes amid longstanding concerns within the sector about regulatory capacity and the role of the Pharmacy Board of Trinidad and Tobago, which oversees pharmacy practice and ensures that medicines sold in the country meet legal and safety standards.
Pouchet noted that the TPSTT continues to promote best practices through its monthly Purple Table Workshops, where pharmacists are encouraged to request regulatory documentation, including Notices of Authorisation, when distributors offer unfamiliar products.
She emphasised that safeguarding the pharmaceutical supply chain requires cooperation among regulators, distributors, pharmacists, and the wider public.
